After cooling off from that massive run, price action has now begun compressing between $13.64 and $16.08, with early signs of base-building before another potential leg up.
🧩 Technical Outlook
Strong rally → deep correction → accumulation structure forming.
Support Levels: $13.64 (core zone), $10.01 (strong confluence), and $7.98 (long-term floor).
Resistance Zones: $19.25 → $22.07 → $26.19.
Channel projection shows potential for re-test of $26.19 by November if current momentum continues.
Higher timeframe targets extend to $30.09 and $34.39 in Q1 2026 if the bullish structure holds.
The setup favors accumulation entries below $16.08, with a short-term target to retest $22.07 and potentially $26.19 once momentum returns.
📰 Recent News & Fundamentals
Critical Metals shares have been volatile following major financing announcements:
📉 Announced offering of 18.03 million shares triggered a short-term selloff.
💰 Confirmed $50 million PIPE financing, strengthening capital for expansion.
🌍 Broader rare-earth momentum continues as China tightens export restrictions and JPMorgan initiates new investments into critical mineral supply chains.
Despite the correction, the sector tailwinds remain strong — and
📊 Sentiment Snapshot (from Schwab QORE Analytics)
Rating: F (Strongly Underperform) – percentile rank 100
26-week price change: +834%
Beta: 1.14
Sector: Materials / Diversified Metals & Mining
High volatility + weak sentiment ratings often precede large technical reversals — a setup that speculative traders should be watching closely.
💡 My Plan
I’m watching for clean accumulation below $16.08 for a potential re-entry swing trade.
Stop: under $13.50
Targets: $22.07 → $26.19 (swing)
Longer-term projections: $30 → $34 if the bullish trend resumes into 2026.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
